Real-World Safety Profile of Biologics Used in Rheumatology: A Six-Year Observational Pharmacovigilance Study in the Calabria Region

Background: The introduction of biological agents into the clinical armamentarium has modified the management of moderate-severe inflammatory arthritis (IA). However, these drugs can lead to serious adverse events (SAEs) and unpredictable adverse events (AEs) that are difficult to detect in pre-mark...

Descripción completa

Detalles Bibliográficos
Autores principales: Gagliardi, Agnese, Iaquinta, Francesco Salvatore, Grembiale, Rosa Daniela, De Sarro, Caterina, Fabiano, Antonio, Fraija, Domenico, Palleria, Caterina, Romeo, Rossella, De Francesco, Adele Emanuela, Naturale, Maria Diana, Citraro, Rita, Gallelli, Luca, Leo, Antonio, De Sarro, Giovambattista
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9697719/
https://www.ncbi.nlm.nih.gov/pubmed/36365146
http://dx.doi.org/10.3390/pharmaceutics14112328

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9697719/
https://www.ncbi.nlm.nih.gov/pubmed/36365146
http://dx.doi.org/10.3390/pharmaceutics14112328

Ejemplares similares